Clinical Trial Update: BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis [Phase 4]

View source ↗

Summary

This document updates the status of BEACON-AA, a Phase 4 trial evaluating apixaban with or without clopidogrel in stroke patients with atrial fibrillation and c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Intracranial Atherosclerosis
• Stroke

Drugs mentioned

• Eliquis (apixaban)
• Plavix (clopidogrel)

Snippet

Sponsor: Yonsei University | Conditions: Stroke, Ischemic | Phase 4 | Status: NOT_YET_RECRUITING